main content start
Farxiga (dapagliflozin) is a type 2 diabetes oral medication in the SGLT-2 inhibitor class of drugs. It blocks glucose from being reabsorbed by the kidneys. Excess glucose is released in the urine. Some medications in the SGLT-2 inhibitor class may offer heart and kidney benefits for people with cardiovascular disease.
Farxiga is approved for adults and children aged 10 years and older with type 2 diabetes.
- Farxiga is used to improve blood glucose management in people with type 2 diabetes.
- Farxiga also reduces the risk of heart failure in adults with type 2 diabetes and cardiovascular disease.
- Farxiga is usually taken once per day with or without food.
- An initial dose is 5 mg daily, which may be increased to a maximum dose of 10 mg if well-tolerated and needed.
- Common side effects may include increased urinary frequency, dizziness, and genital-urinary infections.
Farxiga Specs
Key specification
Generic Name
Dapagliflozin
Approved for Kids
10+
Drug Class
SGLT-2 inhibitors
General Information
Product Name
Farxiga
Product Type
Oral Medications
Brand
AstraZeneca
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
